Magnetic Nano-Platform Enhanced iPSC-Derived Trabecular Meshwork Delivery and Tracking Efficiency

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Biomaterials Science

Background:

• Glaucoma treatment increasingly utilizes stem cell transplantation to restore ocular fluid dynamics and intraocular pressure (IOP).
• Effective delivery and tracking of transplanted cells are critical for successful stem cell therapy in glaucoma.
• Current methods for cell tracking and delivery require enhancement for clinical application.

Purpose of the Study:

• To design and evaluate a novel nanoparticle for labeling induced pluripotent stem cell (iPSC)-derived trabecular meshwork (TM) cells.
• To improve the accuracy of cell delivery and the efficiency of in vivo tracking of transplanted TM cells.
• To assess the impact of nanoparticle-mediated cell tracking on the therapeutic efficacy in a glaucoma model.

Main Methods:

• PLGA-SPIO-Cypate (PSC) nanoparticles were synthesized using polylactic acid-glycolic acid (PLGA), superparamagnetic iron oxide (SPIO), and a near-infrared (NIR) dye (cypate).
• In vitro studies assessed nanoparticle cytotoxicity, iron content, and dual-model monitoring in mouse iPSC-derived TM (miPSC-TM) cells and human TM cells.
• In vivo studies evaluated cell delivery accuracy, long-term tracking, and IOP-lowering effects after miPSC-TM transplantation in mice.

Main Results:

• Nanoparticle incubation effectively labeled iPSC-derived TM cells without affecting cell viability or fate.
• In vivo studies demonstrated improved delivery accuracy and long-term dual-model tracking of transplanted cells.
• Magnetic stimulation transiently enhanced the therapeutic efficacy of cell-based glaucoma treatment.

Conclusions:

• The developed PSC nanoparticle offers a promising strategy for enhancing cell delivery and in vivo tracking in stem cell therapy for glaucoma.
• This approach facilitates the clinical translation of stem cell-based treatments for glaucoma patients.
• Nanoparticle-mediated tracking and magnetic enhancement represent a significant advancement in regenerative ophthalmology.